Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Pharmacocinétique de la population")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 559

  • Page / 23
Export

Selection :

  • and

Fundamentals of Population Pharmacokinetic Modelling: Modelling and SoftwareKIANG, Tony K. L; SHERWIN, Catherine M. T; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 8, pp 515-525, issn 0312-5963, 11 p.Article

Population Pharmacokinetic Analysis during the First 2 Years of Life: An OverviewMARSOT, Amélie; BOULAMERY, Audrey; BRUGUEROLLE, Bernard et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 787-798, issn 0312-5963, 12 p.Article

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Population Pharmacokinetics of Therapeutic Monoclonal AntibodiesDIRKS, Nathanael L; MEIBOHM, Bernd.Clinical pharmacokinetics. 2010, Vol 49, Num 10, pp 633-659, issn 0312-5963, 27 p.Article

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy IndividualsAREBERG, Johan; PETERSEN, Kamilla B; CHEN, Grace et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 115, Num 6, pp 552-559, issn 1742-7835, 8 p.Article

Fundamentals of Population Pharmacokinetic Modelling: Validation MethodsSHERWIN, Catherine M. T; KIANG, Tony K. L; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 9, pp 573-590, issn 0312-5963, 18 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programsFINKELSTEIN, Yaron; NAVA-DCAMPO, Alejandro A; SCHECHTER, Tal et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 53-57, issn 0767-3981, 5 p.Article

Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo SimulationLODISE, Thomas P; GOTFRIED, Mark; BARRIERE, Steven et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2300-2304, issn 0066-4804, 5 p.Article

Performance of Different Population Pharmacokinetic AlgorithmsCOLUCCI, Philippe; GRENIER, Julie; SENG YUE, Corinne et al.Therapeutic drug monitoring. 2011, Vol 33, Num 5, pp 583-591, issn 0163-4356, 9 p.Article

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokersCRONENBERGER, Carol; MOULD, Diane R; ROETHIG, Hans-Juergen et al.British journal of clinical pharmacology. 2008, Vol 65, Num 1, pp 30-39, issn 0306-5251, 10 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and BioavailabilitySAVIC, Radojka M; YANHUI LU; BLIVEN-SIZEMORE, Erin et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3035-3042, issn 0066-4804, 8 p.Article

Influence of Erroneous Patient Records on Population Pharmacokinetic Modeling and Individual Bayesian EstimationDER MEER, Aize Franciscus Van; TOUW, Daniël J; MARCUS, Marco A. E et al.Therapeutic drug monitoring. 2012, Vol 34, Num 5, pp 526-534, issn 0163-4356, 9 p.Article

Interpreting population pharmacokinetic-pharmacodynamic analyses -a clinical viewpointDUFFULL, Stephen B; WRIGHT, Daniel F. B; WINTER, Helen R et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 807-814, issn 0306-5251, 8 p.Article

Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropeniaKANBAYASHI, Yuko; NOMURA, Kenichi; TANIWAKI, Masafumi et al.International journal of antimicrobial agents. 2008, Vol 31, Num 5, pp 452-457, issn 0924-8579, 6 p.Article

Population Pharmacokinetic Analysis of Colistin in Burn PatientsLEE, Jongtae; HAN, Seunghoon; JEON, Sangil et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2141-2146, issn 0066-4804, 6 p.Article

Adaptive Optimal Design for Bridging Studies with an Application to Population Pharmacokinetic StudiesLEE KIEN FOO; DUFFULL, Stephen.Pharmaceutical research. 2012, Vol 29, Num 6, pp 1530-1543, issn 0724-8741, 14 p.Article

Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm InfantsCOHEN-WOLKOWIEZ, Michael; OUELLET, Daniele; KASHUBA, Angela D. M et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 1828-1837, issn 0066-4804, 10 p.Article

Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with InfectionsSAMARA, Emil; SHAW, Jeng-Pyng; BARRIERE, Steven L et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 2067-2073, issn 0066-4804, 7 p.Article

Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patientsPEREZ-RUIXO, Carlos; VALENZUELA, Belén; FERNANDEZ TERUEL, Carlos et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 15-24, issn 0344-5704, 10 p.Article

The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsLANE, Steven; AI-ZUBIEDI, Sameh; KAMALI, Farhad et al.British journal of clinical pharmacology. 2012, Vol 73, Num 1, pp 66-76, issn 0306-5251, 11 p.Article

Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects : Evidence for Injection Interval of Up to 2 MonthsTROCONIZ, Inaki F; CENDROS, Josep-Maria; PERAIRE, Concepcion et al.Clinical pharmacokinetics. 2009, Vol 48, Num 1, pp 51-62, issn 0312-5963, 12 p.Article

  • Page / 23